This invention relates to methods for detection of nucleic acids on a solid phase with high affinity and high specificity. More particularly, the invention relates to methods combining high-affinity hybridization with highly specific enzymatic discrimination in solid phase based nucleic acid assays. This invention further relates to kits containing the reagents necessary for carrying out the disclosed assays. The detection of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) is of importance in human or veterinary diagnostics, food control, environmental analysis, crop protection, biochemical/pharmacological research, or forensic medicine.
In a typical solid phase based nucleic acid assay, capture oligonucleotides are immobilized on a solid support. The labeled or unlabeled nucleic acid target is specifically hybridized to the capture probes. After hybridization and, if necessary, labeling, the hybridization event can be detected using e.g. optical, electrical, mechanical, magnetic or other readout methods. Generally, the high specificity of base pairing interactions between strands of nucleic acids are used in these methods to differentiate between different targets. Using a solid phase enables facile multiplexing of nucleic acid hybridization assays by spatially separating different capture oligonucleotides having different sequences. In addition, the solid phase facilitates separation of bound and unbound species by simple washing steps. A huge number of different supports e.g. planar surfaces (“chips”), beads or gel matrices can be used as solid phases. Methods for preparation of DNA oligonucleotide arrays are summarized e.g. in S. L. Beaucage, Curr. Med. Chem. 2001, 8, 1213-1244 or M. C. Pirrung, Angew. Chem. 2002, 114, 1326-1341. Solid phase based nucleic acid hybridization assays are widely used e.g. for analysis of single nucleotide polymorphisms (SNPs), expression profiling or viral detection (for a summary see e.g. J. Wang, Nucl. Acids Res. 2000, 28, 3011-3016).
An alternative approach for specific detection of nucleic acids employs the specificity of enzymes for the discrimination of different probe-target complexes on solid phases or in solution. For example, in enzymatic SNP assays, the immobilized capture probe can be used as primer for allele-specific primer extension reactions or as one component of allele-specific oligonucleotide ligation reactions. Ligation assays are described e.g. in U.S. Pat. No. 5,800,994 and WO 9631622; primer extension reactions are described e.g. in WO A200058516/US 2001046673/EP 1061135A2. Again, multiplexing of enzymatic nucleic acid assays can be achieved by spatial separation of oligonucleotide probes on a surface.
Chemical oligonucleotide ligation reactions can be used for discrimination between different sequences, analogous to the enzymatic methods mentioned above. For example, WO 9424143 describes chemical ligation of an (α-haloacetyl derivatized oligonucleotide to a second phosphorothioate modified oligonucleotide, spontaneously and selectively forming a covalent bond.
Methods for genotyping single nucleotide polymorphisms are described e.g. in P.-Y. Kwok, Annu. Rev. Genomics Hum. Gen. 2001, 2, 235-258. One current general method for detection of SNPs relies on a three step procedure: purification of genomic DNA from biological material, amplification of the desired gene fragment e.g. by PCR and subsequent detection e.g. by allele specific hybridization, enzymatic reactions etc. Due to the current lack of highly sensitive nucleic acid detection methods, the amplification step is unavoidable. However, this step is very laborious, time consuming, expensive and difficult to multiplex. Therefore, there is a need for assays that allow for highly sensitive, highly selective detection of nucleic acids, e.g. containing SNPs, directly from genomic DNA, without prior amplification.
The present invention is directed to a method for combining high specificity with high sensitivity in order to enable nucleic acid analysis on a solid surface from biological sources without prior amplification.
A solid phase based nucleic acid detection method that employs electrical current to control hybridization reactions is disclosed in WO 9512808. Using electrical current, nucleic acids are actively transported from solution to specific locations on a surface, addressed by electrodes. The method can be used to control and enhance the specificity and sensitivity of nucleic acid hybridization reactions. One serious drawback of this technology is electrolysis that accompanies the electronic addressing process. Thus, a restriction to certain buffer systems exists that imposes the necessity of sample preparation steps. In addition, each hybridization event has to be addressed individually. Therefore, the complexity of electrode structures on the surface increases with the number of analytes to be detected.
An example of a nucleic acid assay which employs multiple hybridization reactions for combination of affinity and specificity is given in WO 95/16055. In this approach, capture probes are bound to a surface. One or more capture extender molecules are employed, each containing a target specific binding sequence and a support binding sequence able to hybridize to the surface bound capture probes. The capture extender sequences are used to bind the target to the support with high affinity. For detection, e.g. amplification multimers are hybridized to the target in order to amplify signals. Different sequences can be discriminated by specific hybridization of capture extenders containing sequences specific to different target regions. In case of targets that differ in their sequences by only one base (e.g. SNPs) this approach does not work for more than one capture extender, because the differences in thermodynamic stabilities and thus melting temperatures are too small for effective discrimination.
A nucleic acid hybridization assay combining affinity and specificity is described by Wanda L. B. White et al. (Poster: “SNP determination by dual hybridization with DNA and PNA probes”, Cambridge Healthtech Institute Conference on Nucleic Acid Based Technologies, Wash. D.C., 2002). An immobilized 40 mer DNA is used to capture the target with high affinity, while a short PNA probe is used for allele-specific hybridization. Drawbacks of this assay principle are (1) long capture sequences are not specific enough for multiplexed assays and (2) for analysis of SNPs a second multiplexing principle (e.g. different colored labels) besides the solid support has to be introduced in order to differentiate between alleles.
In summary, many nucleic acid assay formats, that make use of a hybridization reaction of a target probe to a capture probe immobilized on a solid phase, suffer from either sensitivity or selectivity. Therefore, problems occur if e.g. single nucleotide polymorphisms must be detected in samples without prior target amplification. If the capture probes are designed for maximum affinity and therefore sensitivity of the assay the capturing reaction suffers from selectivity. If the capture probes are designed for maximum selectivity the hybridizaton reaction displays only moderate affinity.
Methods and kits are provided for detecting nucleic acids with high sensitivity and high specificity on a solid support. In general, the methods combine high affinity capture using one or more target specific oligonucleotides with highly specific enzymatic discrimination methods. Preferred methods include the use of one or more capture extender molecules for capturing the target with high affinity, in combination with a “discrimination extender” that is used for enzymatic reactions like ligations or primer extensions thereby specifically incorporating a label.
The invention combines high-affinity oligonucleotide capture with highly specific enzymatic discrimination on a solid support, preferably for the detection of single nucleotide polymorphisms in multiplex assays without prior amplification of genomic DNA. The invention makes use of the fact that enzymatic reactions like polymerase mediated primer extension or ligase mediated oligonucleotide ligation proceed via nucleophilic attack of the free 3′-terminal hydroxyl group on activated 5 5′-terminal phosphate groups of a nucleotide or oligonucleotide, thereby forming a 3′-5′-phosphodiester bond. Therefore, 3′-terminal hydroxyl groups can be easily prevented from polymerase or ligase extensions by blocking. In the disclosed assay format, all oligonucleotides, except for the discrimination extender that is used for enzymatic discrimination, are blocked on their 3′-termini. Capture probes can be blocked against enzymatic reactions by immobilization via their 3′-hydroxyl-termini, eventually employing spacer groups between the 3′-terminus and the group used for immobilization. Other 3′-termini can be blocked against enzymatic processing by using e.g. 3′-deoxynucleotides, 2′,3′-dideoxynucleotides, 3′-phosphates, 3′-aminoalkylphosphates, 3′-alkylphosphates, 3′-carboxyalkylphosphates, 3′-terminal biotin modifications, 3′-terminal inverted nucleotides etc. All modifications mentioned above and other possible blocking modifications can be incorporated using standard oligonucleotide synthesis methods.
The discrimination reaction employed in the disclosed assays can be an enzymatically catalyzed primer extension or oligonucleotide ligation reaction. Alternatively, nonenzymatic, chemical extension methods can be used to achieve allele-specific incorporation of labeling entities. The fidelity of some chemical reactions for oligonucleotide ligation is comparable to enzymatic methods, for an example see K. D. James, A. D. Ellington, Chem. Biol. 1997, 4, 595-605. Enzymatic discrimination relies on a primer that is the perfect complement of one allele sequence. The position of the SNP is preferably situated at the 3′-terminal nucleotide of the primer. In case of ligation reactions the discrimination extender can display an unblocked 3′-terminus with the 3′-terminal nucleotide being complementary to the SNP position. A second, 5′-phosphorylated, labeled oligonucleotide, being complementary to a region of the target neighboring the SNP, is ligated in a ligase mediated reaction thereby introducing the labeling entity. Alternatively, the discrimination extender used for ligase mediated discrimination can display a phosphorylated 5′-terminus with the 5′-terminal nucleotide being complementary to the SNP position. A second, 3′-terminally unblocked labeled oligonucleotide, being complementary to a region of the target neighboring the SNP, is ligated in a ligase mediated reaction thereby introducing the labeling entity.
Using the enzymatic discrimination reaction a number of different labeling entities or entities that allow for labeling reactions, can be specifically incorporated. Since multiplexing of the assay is achieved by spatial separation of discrimination extenders, only one type of label is necessary for the disclosed assays, if SNP analysis is being performed. Labels or groups enabling labeling reactions can be e.g. fluorophors, nanoparticles, redox active moieties, antibodies, antibody fragments, biotin, aptamers, peptides, proteins, mono- or polysaccharides, nucleic acids, nucleic acid analogs, complexing agents, cyclodextrins, crown ethers, anticalins, receptors etc.
Depending on the type of label that has been introduced during the enzymatic or chemical reaction, different readout methods can be used to assess the result of the assay. Examples for readout methods include optical, electrical, mechanical or magnetic detection. More specifically, fluorophores can be detected using e.g. planar optical waveguides as disclosed in U.S. Pat. No. 5,959,292 and WO 99/47705, total reflection on interfaces as disclosed in DE 196 28 002 or using optical fibers as disclosed in U.S. Pat. No. 4,815,843. Nanoparticle labels can be detected e.g. via optical methods or e.g. by direct electrical detection after autometallographic enhancement as disclosed in U.S. Pat. No. 4,794,089, U.S. Pat. No. 5,137,827 and U.S. Pat. No. 5,284,748.
In a first aspect of the invention, an assay is provided in which one or more capture extender molecules are used, each of which must bind to the target molecule at a specific site (
In a second aspect of the invention, an assay is provided in which one or more capture extender molecules are used, each of which must bind to the target molecule at a specific site (
In a third aspect of the invention, an assay is provided in which one or more capture extender molecules are used, each of which must bind to the target molecule at a specific site (
In a fourth aspect of the invention, an assay is provided in which one or more capture probe molecules are used, each of which must bind to the target molecule at a specific site (
In a fifth aspect of the invention, an assay is provided in which one or more capture probe molecules are used, each of which must bind to the target molecule at specific site (
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US03/27201 | 8/29/2003 | WO | 12/8/2005 |
Number | Date | Country | |
---|---|---|---|
60407468 | Aug 2002 | US |